Navigation Links
AV-1011 Bird Repellent to Protect Rice Seed Approved for Use in Louisiana and Missouri

NEW CASTLE, Del., March 12 /PRNewswire/ ---- Arkion(R) Life Sciences has received their first ever Section 18 approvals to market AV-1011 Liquid Rice Seed Treatment in Louisiana and Missouri effective March 6, 2009, through March 6, 2010. The EPA approval means that rice growers in these states can protect their seed from marauding blackbirds and grackles. The new bird repellent effectively stops birds from eating the newly planted seeds and reducing rice yields.

While the product is non-lethal to birds, it has been shown to be highly effective in protecting rice seed during several years of testing. According to Michael Hensgens, Business Manager, G&H Seed Company (Crowley, LA), this allows Louisiana rice producers to plant before over-wintering blackbirds have migrated north. Early planting has several advantages. In the past, many rice producers have delayed planting to avoid the risk of newly planted seeds being eaten by birds. Resulting damage to rice fields causes lower yields and sometimes requires replanting -- both of which are very costly. It also allows producers to plant at a more optimal date which usually results in higher yields. Another real advantage to earlier planting and harvest is reduced hurricane risk. Hurricane Rita in 2005 and Gustave and Ike in 2008 caused massive crop losses to rice not harvested by Labor Day. An early planting date allows producers to complete harvest by August.

Information about approved uses and labels may be found at the Arkion(R) Life Sciences web site:

Arkion(R) Life Sciences has been a pioneer in the development and commercialization of several formulations of bird repellent and bird management technologies. In addition to Avipel(R) for crop protection, Arkion's patented formulations of anthraquinone effectively repel geese from turf grass with FlightControl(R) Plus and birds from structures through Airepel(R) Humane Bird Management.

Arkion(R) Life Sciences LLC, based in New Castle, Delaware, is a technology-based company leading in the discovery, development and marketing of environmentally friendly, natural or nature identical bioactive compounds. Arkion(R) has three major businesses:

Airepel(R), supplying bird repellents which feature a non-lethal method to control where birds feed and roost; Hyperimmune eggs with markets in human and animal nutrition; and Bio-Technical Resources (Manitowoc, WI) which develops processes and products based upon fermentation technology such as glucosamine, N-acetylglucosamine and natamycin.

SOURCE Arkion Life Sciences LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. ORNL super water repellent could cause big wave in market
2. Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System
3. InNexus Biotechnology Announces New Patents Protecting Novel Cell Penetrating DXL(TM) Antibodies
4. N-Viro Fuel Technology Receives Alternative Energy Status From the U.S. Environmental Protection Agency
5. vProtect(TM) Luminal Shield Stabilizes Life-Threatening Plaque
6. Cain and Associates Launches Government Audit Protection (GAP) Service
7. Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
8. Zemea Propanediol Meets U.S. Environmental Protection Agency Design for the Environment Criteria
9. New Radiation-Blocking Medical Garments Introduced at RSNA Meeting in Chicago : Demron-M Technology Provides Total Protection in a Lightweight, Durable, Flexible Fabric
10. UCF professor develops vaccine to protect against black plague bioterror attack
11. SRA Awarded $56 Million Contract by Pentagon Force Protection Agency
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... ... November 25, 2015 , ... Jessica ... on AngelList early in their initial angel funding process. Now, they are paying ... looking to make early stage investments in the microbiome space. In this, ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW/ - iCo Therapeutics ... today reported financial results for the quarter ended ... expressed in Canadian dollars and presented under International ... United States ," said Andrew Rae ... advancements regarding iCo-008 are not only value enriching ...
(Date:11/24/2015)... India , November 24, 2015 ... a new market research report "Oligonucleotide Synthesis Market by ... Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, ... 2020", published by MarketsandMarkets, the market is expected to ... Million in 2015, at a CAGR of 10.1% during ...
Breaking Biology Technology:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... 2015  The J. Craig Venter Institute (JCVI) policy ... and Biosecurity: Lessons Learned and Options for the Future," ... Human Services guidance for synthetic biology providers has worked ... --> --> Synthetic biology promises ... to pose unique biosecurity threats. It now is easier ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
Breaking Biology News(10 mins):